| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.97B | 42.75B | 41.45B | 31.04B | 39.10B | 28.61B |
| Gross Profit | 10.23B | 12.11B | 9.44B | 7.89B | 8.26B | 6.68B |
| EBITDA | 7.73B | 8.27B | 9.13B | 6.40B | 2.06B | 4.21B |
| Net Income | 4.43B | 4.71B | 4.50B | 1.37B | -4.16B | 309.27M |
Balance Sheet | ||||||
| Total Assets | 21.12B | 22.78B | 24.68B | 21.44B | 28.02B | 27.53B |
| Cash, Cash Equivalents and Short-Term Investments | 9.07B | 9.58B | 11.36B | 7.04B | 6.50B | 2.95B |
| Total Debt | 5.88B | 6.17B | 7.30B | 9.88B | 14.93B | 12.16B |
| Total Liabilities | 11.55B | 12.36B | 13.16B | 13.98B | 20.09B | 17.29B |
| Stockholders Equity | 9.58B | 10.43B | 11.53B | 7.44B | 7.91B | 10.23B |
Cash Flow | ||||||
| Free Cash Flow | 3.08B | 6.33B | 8.37B | 5.30B | -663.18M | -3.16B |
| Operating Cash Flow | 3.96B | 7.63B | 9.00B | 6.15B | 3.81B | 2.92B |
| Investing Cash Flow | 678.19M | -91.49M | -5.31B | -756.89M | -4.95B | -4.69B |
| Financing Cash Flow | -6.71B | -7.63B | -3.50B | -4.99B | 4.31B | 2.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$82.61B | 17.57 | 40.94% | 5.78% | -4.96% | 4.93% | |
72 Outperform | HK$1.05B | 9.89 | 12.32% | 5.56% | 4.16% | 59.08% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | HK$2.44B | 39.60 | 1.82% | 1.12% | -6.80% | -85.10% | |
55 Neutral | HK$2.47B | 19.78 | 5.05% | 6.90% | -3.45% | -50.11% | |
50 Neutral | HK$205.41M | 12.23 | 2.32% | 21.88% | 1.02% | -71.48% | |
43 Neutral | HK$470.67M | -2.42 | -51.41% | ― | -21.42% | 55.86% |